Biora Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.566; its P/E ratio is -0.07; Biora Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	$ 2.00K	$ 2.00K	$ 14.00K	$ 80.00K
Gross Profit	-	$ 2.00K	$ 2.00K	$ 14.00K	-
EBIT	$ -70.86M	$ -15.10M	$ -14.76M	$ -8.32M	$ -11.94M
EBITDA	$ -70.37M	$ -14.55M	$ -14.24M	$ -7.79M	$ -11.74M
Net Income Common Stockholders	$ -73.45M	$ -17.81M	$ -17.44M	$ -13.47M	$ -5.11M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 26.45M	$ 30.50M	$ 30.49M	$ 37.06M
Total Assets	$ 34.70M	$ 49.67M	$ 53.24M	$ 53.52M	$ 62.61M
Total Debt	$ 80.40M	$ 128.60M	$ 128.20M	$ 127.81M	$ 129.33M
Net Debt	$ 80.40M	$ 102.15M	$ 97.70M	$ 97.33M	$ 92.27M
Total Liabilities	$ 153.49M	$ 170.59M	$ 158.24M	$ 155.81M	$ 160.06M
Stockholders Equity	$ -118.79M	$ -120.89M	$ -105.00M	$ -102.29M	$ -97.44M
Cash Flow	-
Free Cash Flow	$ -11.04M	$ -11.64M	$ -12.10M	$ -10.94M	$ -9.97M
Operating Cash Flow	$ -11.03M	$ -11.62M	$ -12.10M	$ -10.86M	$ -9.80M
Investing Cash Flow	$ -1.00K	$ -19.00K	$ -6.00K	$ -72.00K	$ -164.00K
Financing Cash Flow	$ -2.85M	$ 7.63M	$ 12.08M	$ 4.52M	$ -1.48M

Currency in USD

Biora Therapeutics Earnings and Revenue History

Income Statement >

Biora Therapeutics Debt to Assets

Balance Sheet >

Biora Therapeutics Cash Flow

Cash Flow >

Biora Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing